February 12, 2014

Indian firms need to focus on IP-led growth: KPMG

  OUR LATEST ON TWITTER

Global Innovation Policy Center (GIPC) @globalIPcenter 1h

Waiving patent rights would hurt not only the American companies that developed COVID-19 vaccines, but the biopharmaceutical sector, medical innovation, and the U.S. economy as a whole. Read more. https://t.co/mPqlGzuxq9

Reply Retweet Favorite


Subscribe for updates from GIPC